Pancreatic Cancer Research

ResearcherTottori UniversityActive in the last 2 years

Yuki Murakami

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109973762. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers

Papers 6

  1. The cachexia index is a prognostic factor for patients with recurrent pancreatic cancer. Co-author DOI 10.1007/s00595-024-02877-z↗
  2. Correlation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenoca… Co-author DOI 10.1097/md.0000000000038292↗
  3. Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer. Co-author DOI 10.33160/yam.2023.05.014↗
  4. Modified geriatric nutritional risk index in patients with pancreatic cancer: a propensity score-matched analysis. Co-author DOI 10.1186/s12885-022-10071-y↗
  5. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer. Co-author DOI 10.1371/journal.pone.0271073↗
  6. Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer. Co-author DOI 10.1038/s41598-021-94711-6↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takehiko Hanaki · 6 shared papers, 2021–2024 · strength 1.03
  2. Teruhisa Sakamoto · 6 shared papers, 2021–2024 · strength 1.03
  3. Yoshiyuki Fujiwara · 5 shared papers, 2021–2024 · strength 0.83
  4. Mikiya Kishino · 2 shared papers, 2024 · strength 0.40
  5. Masaki Morimoto · 3 shared papers, 2021–2022 · strength 0.39
  6. Teppei Sunaguchi · 2 shared papers, 2022 · strength 0.27
  7. Yoshiyuki Fujiwara · 1 shared paper, 2024 · strength 0.20
  8. Hiroyuki Kugoh · 1 shared paper, 2021 · strength 0.12
  9. Takuki Yagyu · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.